Health Innovation

Sweden has developed one of the world’s most innovative life-sciences ecosystems, combining world-class research, entrepreneurial talent, and close collaboration among academia, healthcare providers, industry, and government. This model has helped transform scientific discoveries into new treatments, diagnostics, and technologies that benefit patients worldwide. From multinational companies to fast-growing startups, Sweden’s life-sciences sector is helping address some of healthcare’s most pressing challenges, including cancer, chronic disease, aging populations, and personalized medicine.

The United States and Sweden share a long-standing partnership in health and life sciences. A bilateral agreement between the U.S. Department of Health and Human Services and Sweden’s Ministry of Health and Social Affairs has strengthened cooperation on cancer research, prevention, treatment, and patient care. This collaboration brings together researchers, healthcare providers, industry leaders, and policymakers from both countries to accelerate innovation and improve outcomes for cancer patients. By sharing expertise and best practices, Sweden and the United States are helping translate research discoveries into real-world impact more quickly.

Sweden’s personal identity number system was introduced in 1947 and today helps support one of the world’s most advanced digital-health ecosystems.

Sweden consistently ranks among the world’s leading countries for research and development, supported by internationally recognized universities, extensive health data resources, and a strong culture of innovation. The country is home to globally renowned life-sciences companies including AstraZeneca, which continues to pioneer advances in oncology, rare diseases, and biopharmaceutical research, and Elekta, a world leader in precision radiation therapy and cancer-treatment technologies. Together, these companies are helping improve the lives of millions of patients while contributing to scientific breakthroughs that shape global healthcare. Sweden also has a thriving startup ecosystem. Hundreds of biotechnology, medtech, and digital-health companies are developing new solutions in areas such as AI-assisted diagnostics, cell and gene therapies, precision medicine, and next-generation healthcare technologies. Many of these companies emerge from leading research institutions and benefit from close collaboration with hospitals, universities, and industry partners.

Sweden’s healthcare system, research infrastructure, and extensive biobanks provide a strong foundation for medical innovation. Researchers have access to high-quality health data and longterm population studies that help accelerate the development of new diagnostics, treatments, and personalized therapies. Sweden’s leadership in health innovation is supported by a uniquely integrated digital infrastructure. Every resident has a personal identity number (personnummer), enabling healthcare records, prescriptions, research data, and public services to be linked throughout an individual’s life. Combined with Sweden’s extensive biobanks and research capabilities, this creates powerful opportunities for medical research, disease prevention, precision medicine, and improved patient outcomes.